Who are Prodif's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Diflucan, GRISEOFULVIN, GRISACTIN ULTRA, Fluconazol, FULVICIN P/G 330, Testosteron.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fosfluconazole.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

Prodif — Competitive Intelligence Brief

Prodif (FOSFLUCONAZOLE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: fosfluconazole. Area: Infectious Disease.

marketed fosfluconazole Lanosterol 14-alpha demethylase Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Prodif (FOSFLUCONAZOLE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Prodif TARGET	FOSFLUCONAZOLE		marketed	fosfluconazole	Lanosterol 14-alpha demethylase
Diflucan	fluconazole	Pfizer Inc.	marketed	Azole Antifungal [EPC]	Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase	1990-01-29
GRISEOFULVIN	GRISEOFULVIN, MICROSIZE	COSETTE	marketed	Tubulin Inhibiting Agent [EPC]	Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin
GRISACTIN ULTRA	GRISEOFULVIN, ULTRAMICROCRYSTALLINE	WYETH AYERST	marketed		Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin
Fluconazol	Fluconazol	Azienda Sanitaria-Universitaria Integrata di Udine	marketed		Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase
FULVICIN P/G 330	GRISEOFULVIN, ULTRAMICROSIZE	CHARTWELL RX	marketed		Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin
Testosteron	Testosteron	Gulhane School of Medicine	marketed		Corticosteroid-binding globulin, Alpha-synuclein, Lanosterol 14-alpha demethylase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (fosfluconazole class)

· 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Prodif — Competitive Intelligence Brief. https://druglandscape.com/ci/fosfluconazole. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab